FRASCHINI, FRANCO LUIGI
 Distribuzione geografica
Continente #
EU - Europa 5.197
NA - Nord America 4.545
AS - Asia 4.133
Continente sconosciuto - Info sul continente non disponibili 691
SA - Sud America 324
AF - Africa 103
OC - Oceania 19
Totale 15.012
Nazione #
US - Stati Uniti d'America 4.282
GB - Regno Unito 1.999
SG - Singapore 1.266
CN - Cina 1.227
IT - Italia 772
SE - Svezia 557
RU - Federazione Russa 448
DE - Germania 400
HK - Hong Kong 384
VN - Vietnam 293
FR - Francia 231
BD - Bangladesh 220
BR - Brasile 200
IN - India 200
CA - Canada 199
IE - Irlanda 173
TR - Turchia 162
KR - Corea 161
NL - Olanda 160
UA - Ucraina 158
FI - Finlandia 106
EU - Europa 81
CO - Colombia 51
GR - Grecia 49
CI - Costa d'Avorio 47
JP - Giappone 43
ID - Indonesia 29
MX - Messico 26
PL - Polonia 24
IQ - Iraq 21
PH - Filippine 21
BE - Belgio 20
AR - Argentina 18
AU - Australia 17
ES - Italia 16
EC - Ecuador 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
PK - Pakistan 12
ZA - Sudafrica 12
CL - Cile 11
RO - Romania 11
HU - Ungheria 10
MY - Malesia 10
PY - Paraguay 10
TN - Tunisia 10
JM - Giamaica 9
PE - Perù 9
SA - Arabia Saudita 9
VE - Venezuela 9
AT - Austria 8
TH - Thailandia 8
UZ - Uzbekistan 8
IR - Iran 7
KE - Kenya 7
EG - Egitto 6
IL - Israele 6
KZ - Kazakistan 6
PT - Portogallo 6
BB - Barbados 5
BG - Bulgaria 5
CZ - Repubblica Ceca 5
JO - Giordania 5
MA - Marocco 5
OM - Oman 5
DK - Danimarca 4
ET - Etiopia 4
LU - Lussemburgo 4
NI - Nicaragua 4
NP - Nepal 4
PR - Porto Rico 4
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
DZ - Algeria 2
HR - Croazia 2
HT - Haiti 2
LV - Lettonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
DO - Repubblica Dominicana 1
GM - Gambi 1
IS - Islanda 1
KG - Kirghizistan 1
LB - Libano 1
Totale 14.388
Città #
Southend 1.847
Singapore 710
Ashburn 368
Hong Kong 364
Chandler 318
Beijing 276
Milan 247
San Jose 242
Seattle 230
Council Bluffs 209
Dallas 209
Santa Clara 192
Princeton 188
Dublin 174
Los Angeles 141
Wilmington 138
Jacksonville 106
Ann Arbor 102
Bengaluru 92
Redmond 90
Toronto 87
New York 86
Boardman 81
Dearborn 76
Mountain View 76
Lauterbourg 72
Hanoi 67
Buffalo 66
Ho Chi Minh City 63
Nanjing 63
Des Moines 60
Shanghai 56
Sakarya 55
Jinan 50
Somerville 50
Guangzhou 49
Abidjan 47
Athens 47
Serra 46
The Dalles 43
Andover 40
Bogotá 40
Moscow 40
Ottawa 38
Shenyang 38
Munich 37
Frankfurt am Main 35
Hanover 35
Houston 35
Columbus 34
Woodbridge 33
Tokyo 32
Tianjin 31
London 30
Nanchang 30
Changsha 29
Rome 29
Dong Ket 28
Hebei 28
Eitensheim 27
Phoenix 25
Fairfield 24
Falls Church 24
Hefei 24
Seoul 24
Shenzhen 24
Brussels 20
Helsinki 19
Kent 19
Warsaw 19
Bitonto 18
Cangzhou 18
Da Nang 18
São Paulo 18
Haikou 16
Redwood City 16
Zhengzhou 16
Chicago 14
Fuzhou 14
Hamburg 14
Stockholm 14
Ningbo 13
Jiaxing 12
Paris 12
Atlanta 11
Jakarta 11
San Diego 11
Berlin 10
Brooklyn 10
Kunming 10
Naples 10
Philadelphia 10
Surrey 10
Auburn Hills 9
Dhaka 9
Hangzhou 9
Kuala Lumpur 9
Montreal 9
Mumbai 9
Roxbury 9
Totale 8.743
Nome #
Effetti clinici della melatonina nei pazienti critici ad alto rischio 433
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm 348
Pharmacokinetics of orally administered melatonin in critically ill patients 333
Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems 321
Melatonin reduces the need for sedation in ICU patients : a randomized controlled trial 319
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation 308
N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands 298
La melatonina riduce la necessità di sedativi e di analgesici in pazienti critici ad alto rischio 297
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN) 285
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells 265
Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia 263
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling 251
Redox balance in patients with Down's syndrome before and after dietary supplementation with α-lipoic acid and L-cysteine 251
Transdermal apomorphine permeation from microemulsions : a new treatment in Parkinson's disease 241
The natural antioxidant alpha-lipoic acid induces p27(Kip1)-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells 241
Bactericidal kinetics of an in vitro infection model of once-daily ceftriaxone plus amikacin against gram-positive and gram-negative bacteria 230
Terapia farmacologica dell'influenza e delle sue complicanze 226
Effect of antibiotics on bordetella pertussis adhering activity: hypothesis regarding mechanism of action 226
Human pharmacokinetics and distribution in various tissues of ceftriaxone 224
Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue 224
Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients 221
Penetration of amphotericin B in human lung tissue after single liposomal amphotericin B (AmBisome) infusion 216
Melatonin delivery in solid lipid nanoparticles : prevention of cyclosporine A induced cardiac damage 214
Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists 213
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin 209
Erratum: The natural antioxidant alpha-lipoic acid induces p27Kip1-dependent cell cycle arrest and apoptosis in MCF-7 human breast cancer cells (European Journal of Pharmacology (2010) 641 (29-34)) 209
Comparison of miocamycin versus amoxycillin in lower respiratory tract infections in children. Clinical response and effect on natural killer activity 198
Influence of protein binding on the pharmacodynamics of ceftazidime or ceftriaxone against gram-positive and gram-negative bacteria in an in vitro infection model 197
Neuroendocrine, immunohistochemical, and ultrastructural study of pineal region tumors 197
Relation between lymphocyte subpopulations and pineal function in patients with early or metastatic cancer 196
Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions 194
Aging and vestibular system: specific tests and role of melatonin in cognitive involvement 193
Synthesis and biology of melatonin and related indole analogs 190
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands : requirements for subtype selectivity and intrinsic activity modulation 189
IN VITRO COMPARATIVE DYNAMICS OF MODIFIED RELEASE CLARITHROMYCIN AND OF AZITHROMYCIN 188
The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxy clarithromycin 187
Measurement of cefaclor and amoxicillin-clavulanic acid levels in middle-ear fluid in patients with acute otitis media 186
2-[125i]iodomelatonin binding in normal and neoplastic tissues 185
Synthesis and the biological activity of new melatonin dimeric derivatives 179
Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands 179
Evaluation of the immunostimulating activity of erythromycin in man 175
Ceftezole levels in serum, bronchial secretun and pulmonary tissue 174
2-N-acylaminoalkylindoles : design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists 169
Ultradian chronomodulation by melatonin of a Placebo effect upon human killer cell activity 167
Characterization and mapping of melatonin receptors in the brain of three mammalian species : rabbit, horse and sheep. A comparative in vitro binding study 163
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain 162
Compartimenti intracellulari batterici e distribuzione intra-cellulare dei chemioantibiotici 161
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765 : Comparison with melatonin and diazepam 160
Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue 159
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 157
The MT2 melatonin receptor subtype is present in human retina and decreases in Alzheimer's disease 154
Changes in th circadian rhythm of ornithine decarboxylase in rat liver during chemical hepatocarcinogenesis 153
Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease 152
Comparison of the rat pinealocyte ultrastructure with melatonin concentrations during daytime and at night 152
The diffusion of clarythromycin and roxithromycin into nasal mucosa, tonsil and lung in humans 151
Melatonin reduces the need for sedation in ICU patients: A randomized controlled trial 145
Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands 145
Regulation of the androgen receptors in the harderian gland of the male Syrian hamster: influence of photoperiod, castration, and chronic melatonin treatment 144
NO-donor melatonin derivatives : synthesis and in vitro pharmacological characterization 142
Enhancement of ornithine decarboxylase activity in rat adenohypophysis after pinealectomy 142
2-[125I]iodomelatonin binding sites in the bovine hippocampus are not sensitive to guanine nucleotides 142
Melatonin and immunity 140
Alpha-1 adrenoceptor involvement in the control of melatonin secretion in the golden hamster 139
Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT2 Melatonin Receptor Ligand 138
Melatonin in patients with chronic tinnitus 129
Humoral and cellular immunoresponse of mice treated with pyrazole-carboxamide-4-amino (PCA). 129
Pineal gland and polyamines 128
Failure of prazosin to mimic the effects of melatonin under in vivo and in vitro conditions 127
The melatonin receptor in the human brain: cloning experiments and distribution studies 126
Symptomatic Spinal Degenerative Pathologies: Clinical Results with the Application of Conservative Biochemical Treatments 125
Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease 123
Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease 123
Comparative study on the electrophysiological responses at thalamic level to different analgesic peptides 121
Treatment of symptomatic lumbar spinal degenerative pathologies by means of combined conservative biochemical treatments 121
Cytosolic androgen receptors in the neuroendocrine tissues of the golden hamster: influence of photoperiod and melatonin treatment 119
Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache 116
Effects of pinealectomy on the circadian rhythms of the activities of polyamine biosynthetic decarboxylases and tyrosine adminotransferase in different organs of the rat 113
Endocrine regulation of thymic biosynthetic polyamine decarboxylases in adult rat 113
Pharmacokinetics and tissue distribution of miocamycin 89
Totale 15.012
Categoria #
all - tutte 37.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.008


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022836 0 0 55 60 59 87 65 38 122 69 107 174
2022/20231.168 191 129 111 119 122 239 21 63 116 4 36 17
2023/2024607 25 61 31 48 157 19 13 20 8 42 69 114
2024/20251.776 71 176 36 207 162 57 21 202 79 160 157 448
2025/20263.913 441 227 459 301 369 286 564 192 347 271 236 220
2026/2027612 239 307 66 0 0 0 0 0 0 0 0 0
Totale 15.012